DOI: http://dx.doi.org/10.18203/2349-2902.isj20211840

Post traumatic cutaneous mucormycosis: a diagnostic dilemma

Kharishma P. Nair, Siddartha Gowthaman S., Meghana S. Bagalgotkar, Vinoth S., Ramanathan Manickam

Abstract


The incidence of mucormycosis, an invasive fungal disease, is more in the developing countries, especially among the immunocompromised individuals. However, this disease can also occur in those without any predisposing factors. In the developed countries, those undergoing haematopoetic stem cell transplantation were more prone to developing this disease. There can be varied presentations of mucormycosis. It could be rhinocerebral, pulmonary, cutaneous, gastrointestinal or even disseminated forms. Post traumatic mucormycosis is infrequently reported and is often difficult to diagnose earlier due to its unusual presentation. In this case report, we describe two patients who acquired cutaneous mucormycosis following traumatic wounds and how they characteristically presented with 3 zones which was identified by us and has not been reported of earlier. This can help in diagnosis of this condition earlier and to follow the treatment protocol accordingly and prevent the morbidity and mortality associated with this disease.


Keywords


Mucormycosis, Amphotercin B, Trauma, Burns

Full Text:

PDF

References


Sarvestani SA, Pishdad G, Bolandparvaz S. Predisposing Factors for Mucormycosis in Patients with Diabetes Mellitus; An Experience of 21 Years in Southern Iran. Bull Emerg Trauma. 2013;1(4):164-70.

Simbli M, Hakim F, Koudieh M, Tleyjeh IM. Nosocomial post-traumatic cutaneous mucormycosis: a systematic review. Scand J Infect Dis. 2008;40(6-7):577-82.

Walsh TJ, Hospenthal DR, Petraitis V, Kontoyiannis DP. Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma. J Fungi (Basel). 2019;5(3):57.

Ahmadinejad Z, Khazraiyan H, Ghanbari F, Ahmadi B, Gerami Shoar M. Cutaneous Mucormycosis in a Diabetic Patient following Traditional Dressing. Case Rep Dermatol Med. 2013;894927.

Tyll T, Lyskova P, Hubka V, Muller M, Zelenka L, et al. Early Diagnosis of Cutaneous Mucormycosis Due to Lichtheimia corymbifera After a Traffic Accident. Mycopathologia. 2016;181(1-2):119-24.

Leclercq A, Cinotti E, Labeille B, Perrot JL, Cambazard F. Ex vivo confocal microscopy: a new diagnostic technique for mucormycosis. Skin Res Technol. 2016;22(2):203-7.

Skiada A, Rigopoulos D, Larios G, Petrikkos G, Katsambas A. Global epidemiology of cutaneous zygomycosis. Clin Dermatol. 2012;30(6):628-32.

Kontoyiannis DP, Lewis RE. How I treat mucormycosis. Blood. 2011;118(5):1216-24.

van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis. 2006;42(7):61-5.

Downie ML, Alghounaim M, Davidge KM, Yau Y, Walsh TJ, Pope E, Somers GR, Waters V, Robinson LA. Isolated cutaneous mucormycosis in a pediatric renal transplant recipient. Pediatr Transplant. 2018;22(4):13172.